Acumen Pharmaceuticals Inc

NASDAQ:ABOS  
7.94
-0.19 (-2.34%)
Earnings Announcements

Acumen Pharmaceuticals Reports Financial Results For Third Quarter 2021

Published: 11/15/2021 13:35 GMT
Acumen Pharmaceuticals Inc (ABOS) - Acumen Pharmaceuticals Reports Financial Results for Third Quarter 2021 and Business Highlights.
Acumen Pharmaceuticals Inc - Qtrly Net Loss $3.9 Million.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.14

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.17

More details on our Analysts Page.